Sweden
· Delayed Price · Currency is SEK Prolight Diagnostics AB Statistics
Total Valuation
Prolight Diagnostics AB has a market cap or net worth of SEK 179.03 million. The enterprise value is 164.07 million.
| Market Cap | 179.03M |
| Enterprise Value | 164.07M |
Important Dates
The next estimated earnings date is Friday, February 21, 2025.
| Earnings Date | Feb 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Prolight Diagnostics AB has 702.09 million shares outstanding. The number of shares has increased by 74.87% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 702.09M |
| Shares Change (YoY) | +74.87% |
| Shares Change (QoQ) | +9.09% |
| Owned by Insiders (%) | 7.42% |
| Owned by Institutions (%) | 3.80% |
| Float | 650.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.34 |
| PB Ratio | 1.34 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.18 |
| EV / Sales | 5.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.89 |
Financial Position
The company has a current ratio of 0.99
| Current Ratio | 0.99 |
| Quick Ratio | 0.99 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -561.11 |
Financial Efficiency
Return on equity (ROE) is -94.36% and return on invested capital (ROIC) is -59.10%.
| Return on Equity (ROE) | -94.36% |
| Return on Assets (ROA) | -43.18% |
| Return on Capital (ROIC) | -59.10% |
| Revenue Per Employee | 1.81M |
| Profits Per Employee | -8.69M |
| Employee Count | 16 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.62% in the last 52 weeks. The beta is 2.38, so Prolight Diagnostics AB's price volatility has been higher than the market average.
| Beta (5Y) | 2.38 |
| 52-Week Price Change | +2.62% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.18 |
| Relative Strength Index (RSI) | 59.87 |
| Average Volume (20 Days) | 6,646,665 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Prolight Diagnostics AB had revenue of SEK 28.98 million and -139.04 million in losses. Loss per share was -0.28.
| Revenue | 28.98M |
| Gross Profit | 28.98M |
| Operating Income | -139.34M |
| Pretax Income | -139.04M |
| Net Income | -139.04M |
| EBITDA | -138.04M |
| EBIT | -139.34M |
| Loss Per Share | -0.28 |
Balance Sheet
| Cash & Cash Equivalents | 14.97M |
| Total Debt | n/a |
| Net Cash | 14.97M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 114.03M |
| Book Value Per Share | 0.19 |
| Working Capital | -148,758 |
Cash Flow
In the last 12 months, operating cash flow was -22.76 million and capital expenditures -5.10 million, giving a free cash flow of -27.86 million.
| Operating Cash Flow | -22.76M |
| Capital Expenditures | -5.10M |
| Free Cash Flow | -27.86M |
| FCF Per Share | -0.04 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -480.76% |
| Pretax Margin | -479.73% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Prolight Diagnostics AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -74.87% |
| Shareholder Yield | -74.87% |
| Earnings Yield | -77.66% |
| FCF Yield | -15.56% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Prolight Diagnostics AB has an Altman Z-Score of -1.31. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.31 |
| Piotroski F-Score | n/a |